FDA Import Refusal 799-3917397-5/21/1 — Canadian Compounding Pharmacy
The FDA refused shipment 799-3917397-5/21/1 from Canadian Compounding Pharmacy (Canada) on Nov 22, 2019. The refused product falls under Drugs and Biologics — NALTREXONE (ANTAGONIST). Cited charge: 75
Refusal details
- Date
- Nov 22, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 60TDB15 NALTREXONE (ANTAGONIST)
- Charges
- 75